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Introduction 
The focus of our research has been the various diseases of the human skin, and 
specifically their molecular background. Acne is one of the most common human 
skin diseases. Although not directly life-threatening, particularly severe forms can 
greatly impair the patients’ quality of life and lead to secondary psychiatric disorders. 
Given that currently available therapeutic agents (although they are effective in 
relieving the symptoms of the disease) can cause serious side effects, there is a great 
unmet need for a deeper understanding of the biology of sebaceous glands (SGs) and 
the identification of new therapeutic approaches with more favorable side effect 
profiles. 
Our team has previously demonstrated that the endocannabinoid system (ECS) 
and, more broadly, multifaceted cannabinoid signaling, regulate the biological 
processes of SGs in a context-dependent, varied manner. Inhibition of 
endocannabinoid (eCB) degradation as well as direct eCB treatment enhances sebum 
lipid synthesis, while the non-psychotropic phytocannabinoid (pCB), (-)-cannabidiol 
(CBD) – which is already used in neurological clinical practice – exhibits complex 
anti-acne effects. These include quantitative and qualitative normalization of sebum 
lipid production, anti-proliferative and anti-inflammatory activities in vitro (in cell 
culture), ex vivo (in whole thickness human skin organ culture), and in vivo 
(according to the latest clinical studies where CBD was applied in a topical 
formulation). 
Given that there are no data in the literature on the effects of pCBs other than 
CBD on sebocytes, several non-psychotropic pCBs ((-)-cannabichromene [CBC], 
(-)-cannabidivarin [CBDV]), (-)-cannabigerol [CBG], (-)-cannabigerovarin [CBGV] 
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and (-)-Δ9-tetrahydrocannabivarin [THCV]) were analyzed in human sebocytes, and 
are reported in the present study. 
Nicotinic acid (niacin; NA) and nicotinamide are members of the vitamin B3 
complex, the absence of which leads to the development of diarrhea, dementia, 
dermatitis, and a special type of SG disorder (“dyssebacia”). NA is also effective at 
treating certain dyslipidemias at pharmacological doses (through activation of the 
hydroxycarboxylic acid receptor 2 [HCA2]). Given that side effects of NA at the 
pharmacological dose include dry skin, whereas NA deficiency may lead to the 
development of a SG disorder, in the second part of our study we investigated how 
NA influences the biological processes of sebocytes. 
Aims 
In the light of the above, we have aimed to answer the following questions in 
the framework of the studies presented in this dissertation: 
 
1. Do other non-psychotropic pCBs similar to CBD, namely CBC, CBDV, 
CBG, CBGV and THCV, influence the biological processes of human sebocytes? 
 
2. Does NA affect the basal (homeostatic) and acne-related pathologically 
increased sebaceous lipid production, cell proliferation, and possibly the immune 
profile of sebocytes and, if so, does it exert its effects via the HCA2 receptor? 
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Materials and Methods 
Culturing and treatment of human immortalized SZ95 sebocytes 
SZ95 sebocytes were cultured in Sebomed™ Basal Medium supplemented with 
10% (V/V) heat inactivated fetal bovine serum, 1 mM CaCl2, 5 ng/ml human 
recombinant epidermal growth factor, and MycoZap™ Plus-CL. The medium was 
changed every two days and in order to prevent confluence-induced differentiation 
of the cultures, the cells were passaged at 60-70% confluency. Mycoplasma 
contamination of our cultures was tested regularly with the MycoAlert™ PLUS 
Mycoplasma Detection Kit, and in each case a negative result was obtained. 
Cultivation was carried out in humidified atmosphere (5% CO2) at 37°C. To exclude 
possible non-specific solvent effects (except for NA directly dissolved in the 
medium), a stock solution of was prepared and stored at -20°C or 4°C as 
recommended by the manufacturer. Stock solutions were diluted 1:1000 immediately 
prior to treatment in cell culture medium, making sure that the treatments being 
compared always had the same “vehicle background”. Cells treated with the vehicle 
of the materials were used as controls. 
Determination of intracellular lipid content of sebocytes 
For the semiquantitative assay of lipid production, fluorescent Nile Red labeling 
was used. Cells were plated on 96-well plates for special fluorescence measurements 
(20 000 cells/well; 24- and 48-hour treatments), and then subjected to appropriate 
treatments. After removing the supernatant, 100 µl of Nile Red solution in PBS (final 
concentration: 1 µg/ml) was added to the cells and incubated for 30 minutes at 37°C. 
The fluorescence intensity of each well was detected using a FlexStation™ II384 or 
FlexStation 3 multimode plate reader using appropriate wavelengths (excitation 
wavelength: 485 nm; emission wavelength: 565 nm). 
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Determination of cellular viability (MTT assay) 
Cells were plated in 96-well plates at 20 000 cells/well, and treated with various 
concentrations of the appropriate materials. After removing the supernatant, 100 µl 
of MTT solution (final concentration: 0.5 mg/ml) in PBS was pipetted into each well 
and incubated at 37°C for 2-3 hours. The MTT solution was then removed, 100 μl of 
“MTT solubilizing solution” was added to each well, and cell-derived formazan 
crystals were quantitated at 565 nm using the FlexStation 3 plate reader previously 
mentioned. 
Determination of apoptosis and necrosis 
Fluorescence measurements of mitochondrial membrane potential were 
performed with the MitoProbe™ DilC1(5) Assay Kit to investigate apoptosis. In 
addition to apoptosis, the presence of necrotic processes in the same specimens was 
examined by simultaneous fluorescent SYTOX Green labeling, which can bind to 
nuclear DNA in the case of membrane disintegration. The sebocytes were plated at 
20 000 cells/well in 96-well plates and treated as indicated. After the supernatant was 
removed, cells were incubated for 30 min at 37°C with DilCl(5) (1:200) and SYTOX 
Green (1 µM) diluted in PBS (50 μl/well). At the end of the incubation, cells were 
washed twice with 100 µl/well PBS and the fluorescence intensity was measured 
using a FlexStation 3 fluorescent plate reader (DilC1(5) excitation/emission 
wavelengths: 630/670 nm; SYTOX Green excitation/emission wavelengths: 490/520 
nm). Positive controls for apoptosis and necrosis were CCCP (1:200; 37 °C for 30 
min) and lysis buffer (1:100; 37 °C for 30 min), respectively. 
Determination of proliferation (CyQUANT proliferation assay) 
Cells were plated on 96 well plates at 2 000 cells/well and treated as indicated. 
The supernatant was then removed and the plates were placed at -80°C until 
measurement, which permeabilized the cells. Subsequently, 200 μl of CyQUANT 
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GR stock solution diluted according to the manufacturer’s protocol was added to 
each well and incubated for 5 minutes at room temperature, protected from light. 
Fluorescence intensity was detected using a FlexStation 3 (excitation wavelength: 
480 nm; emission wavelength: 520 nm). 
Quantitative real-time polymerase chain reaction (Q-PCR) following reverse 
transcription 
Following reverse transcription, quantitative real-time polymerase chain 
reaction was performed on a Roche LightCycler 480 System using a 5’ nuclease 
assay. Total RNA was isolated using TRIzol and subjected to DNase treatment. 
Subsequently, cDNA was prepared from 1 µg of RNA. The Q-PCR reaction was 
performed with TaqMan assays. Expression of 18S RNA or GAPDH was determined 
as an internal control. 
Immunofluorescent Labeling (IF) 
Cells were fixed with 4% paraformaldehyde diluted in PBS in a humid chamber 
at room temperature (5 min). Blocking of non-specific binding sites was done after 
washing with PBS in PBS containing 30 mg/ml BSA (bovine serum albumin) for 30 
minutes at room temperature in a humidified chamber. The cells were incubated for 
4 hours with primary antibody against human HCA2 produced in rabbit at 37°C. The 
coverslips were then washed three times in PBS and incubated for 60 minutes at 
room temperature with Alexa Fluor® 488-conjugated secondary antibody against 
rabbit immunoglobulin Fc segment. Finally, after washing three times with PBS, 
cells were mounted using Vectashield mounting medium containing 4’,6-diamidino-
2-phenylindol (DAPI) as a nuclear stain. Cells were photographed using an Olympus 
IX81 fluorescence microscope (excitation/emission: 488/519 nm [Alexa Fluor® 488] 
and 360/460 nm [DAPI]). As a negative control, our coverslips were stained with the 
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omission of the primary antibody. The mean gray value of the images (detected in 
the green channel, using the same settings for each image exposure) was determined 
by Fiji software and normalized to the background (i.e., the mean gray value of the 
cell-free area) when quantified. 
Cytokine release assay (IL-6 and IL-8 ELISA) 
In the cytokine release assay, cells plated in a standardized manner (500 000 
cells in 1.5 ml medium, 35 mm diameter Petri dishes) were treated as indicated for 3 
and 24 hours. The supernatants were then collected, centrifuged (500 g; 10 min) and 
the debris-free supernatant was stored at -80°C. The amount of IL-6 and IL-8 
released was determined using OptEIA kits according to the manufacturer’s protocol. 
Selective gene silencing (siRNA transfection) 
SZ95 sebocytes were plated in Petri dishes, 96-well plates, or sterile coverslips 
in 6-well dishes, and the next day at 50-70% confluency, the medium was replaced 
with serum-free OptiMem medium and cells were duplexed with specific HCA2-
specific small interfering RNA (siRNA) oligonucleotides using Lipofectamine® 
RNAi MAX transfection reagent. As a control, cells were transfected with Stealth 
RNAi Negative Control “medium” double-stranded siRNA, which does not show 
homology to any known mRNA sequence. The efficiency of gene silencing was 
checked at mRNA (Q-PCR) and protein level (immunofluorescent labeling) on days 
2 and 3 after transfection. 
Fluorescent Ca2+ measurement 
To investigate the effects of NA on Ca2+ homeostasis, Fluo-4 AM labeling was 
used. The sebocytes were plated in 96-well plates at 20 000 cells/well. During the 
assay, cells were washed once with 100 µl/well Hank’s solution supplemented with 
BSA and probenecid to prevent non-specific carrier-mediated Fluo-4 leakage. After 
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washing, the cells were loaded with Hank’s solution (100 µl/well; final 
concentration: 1 µM) containing Fluo-4 AM (30 min, 37°C), followed by three 
additional washing steps (100 µl/well Hank’s solution or nominally Ca2+-free Hank’s 
solution with equimolar glucose instead of CaCl2). Finally, 150 µl Hank’s solution 
or nominally Ca2+-free Hank's solution was pipetted to the wells, and cells were 
incubated for another 30 min at 37°C. The measurement was then performed in Flex 
mode of a FlexStation 3 plate reader at room temperature (excitation wavelength: 
490 nm; emission wavelength: 520 nm). 
Statistical analysis 
Data were analyzed using IBM SPSS Statistics 19 and Origin Pro Plus 6.0 
software. Data was evaluated with Student’s two-tailed, two-sample t-test (pairwise 
comparisons), or Bonferroni post hoc tests (multiple comparison) following one-way 
ANOVA. p<0.05 values were considered as a significant differences in all cases. The 
graphs were plotted using Origin Pro Plus 6.0 software. 
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Results 
pCBs influence the viability of sebocytes in a dose-dependent manner 
Our previous findings revealed that human SGs have a functionally active ECS, 
which plays a role in regulating sebocyte differentiation and thereby lipid production. 
Further, it has been shown that the use of the non-psychotropic pCB CBD at low 
micromolar concentrations leads to complex anti-acne effects. Accordingly, at the 
beginning of our experiments, we sought to determine whether the five pCBs we 
selected produced similar effects on SZ95 sebocytes as CBD. As the starting point 
of investigating each drug, we wanted to determine the effective dose range that did 
not significantly affect cell viability, so we first performed an MTT assay. The five 
selected pCBs did not significantly reduce cell viability after 48 hours compared to 
control. In contrast, at higher concentrations (50-100 μM), there was a significant 
decrease in MTT signal intensity even after 24 hours of treatment. Based on the 
results of the MTT assay performed in the higher concentration range, the use of 
pCBs, even at lower concentrations (i.e., ≤10 μM), may induce early cell death 
processes that do not alter the MTT assay. To resolve this issue, we combined 
DilC1(5) and SYTOX Green labeling. We found that none of the selected pCBs 
increased the proportion of necrotic or apoptotic cells at 10 µM. However, higher 
concentrations of pCBs (50-100 μM) resulted in apoptosis-dominated cell death, as 
they all significantly reduced the mitochondrial membrane potential (DilC1(5)) and 
did not (CBG, CBGV, CBC, and CBDV) or only slightly (THCV) increased the 
signal intensity of SYTOX Green. 
pCBs have varied effects on the sebum lipid production of human sebocytes 
We next examined the effect of pCBs on one of the most important biological 
functions of sebocytes, homeostatic sebaceous lipid production. Not surprisingly, 
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cytotoxic (≥50 μM) concentrations of pCBs typically significantly reduced basal 
sebaceous lipid synthesis. In contrast, pCBs used at non-cytotoxic concentrations 
(≤10 μM) showed intriguing differences in their effects. Based on the effects we 
classified the five substances into three functionally different (“eCB-like”, lipogenic, 
“CBD-like”, i.e., neutral, or lipostatic) groups. According to our results, “eCB-like” 
CBG and CBGV slightly, but significantly increased sebaceous lipid production. In 
contrast, CBDV produced a “CBD-like” effect, in that there was no significant 
change, whereas CBC and THCV significantly reduced it. These results suggested 
that CBC and THCV may have therapeutic potential in seborrhea and acne, whereas 
CBG and CBGV may have therapeutic potential in skin dryness, which is why we 
continued our experiments in this direction. 
CBG and CBGV reduce the lipogenic effect of AEA 
First, we looked at the surprising, “eCB-like” lipogenic effects of CBG and 
CBGV, and examined the effect of co-administration with the eCB AEA. 
Interestingly, we found that CBG and CBGV did not increase the lipogenic effect of 
AEA, and in fact, they significantly reduced it in 20 (CBGV) and 10-20 μM (CBG). 
This suggests that CBG and CBGV may be weak partial activators of the AEA 
lipogenic pathway. 
CBC, CBDV and THCV reduce AA-induced, acne-modeling, pathologically 
enhanced lipogenesis 
As mentioned above, an important step in the pathogenesis of acne is the 
increase of sebaceous production, as well as a change in its composition. 
Normalization of these changes is therefore an important goal in the treatment of the 
disease. Accordingly, we further investigated the effects of THCV, CBC, and CBDV 
on AA-induced, “acne-like”, pathologically enhanced lipid synthesis. Both CBC and 
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CBDV were found to reduce AA-induced lipid synthesis, but these effects were far 
surpassed by THCV, which, like CBD, completely normalized sebaceous lipid 
production. Given that THCV was found to be the most potent of the three pCBs 
based on these results, we investigated the potential anti-acne effects of non-
cytotoxic concentrations of THCV in our subsequent experiments. 
THCV exerts a universal lipostatic effect at non-cytotoxic concentrations 
In the following experiments, we determined whether this remarkable lipostatic 
effect of THCV was limited to the prevention of AA-induced, predominantly protein 
kinase C δ-mediated lipid production, or by activation of a universal lipostatic 
pathway. We performed Nile Red labeling using two eCBs, AEA and 2-AG, acting 
on two lipogenic pathways other than AA. We found that, like CBD, THCV is able 
to normalize the lipogenic effect of both eCBs, i.e., it has a universal lipostatic effect.  
Non-cytotoxic concentrations of THCV are anti-proliferative in human 
sebocytes 
In addition to the increased lipid production of individual sebocytes, the 
proliferation of cells plays a key role in the development of acne-related seborrhea 
(due to the holocrine secretory mechanism). As such, reducing proliferation alone 
can be highly effective in reducing sebum production, and as a next step in our 
experiments, we investigated the effects of THCV on cell numbers. Using the 
CyQUANT proliferation assay, we demonstrated that THCV reduced the 
proliferation of sebocytes in a dose-dependent manner over a concentration range of 
1-10 μM. 
THCV has a potent anti-inflammatory effect 
In addition to pathologically increased lipogenesis and proliferation, the third 
important sebocyte-specific step in acne pathogenesis is inflammation, and therefore, 
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the effects of THCV on the immune profile of sebocytes were investigated. The 
inflammatory response was induced using the TLR4 activator lipopolysaccharide 
(LPS; 5 μg/ml), and measured by the detection of certain “acne-relevant” 
inflammatory cytokines (namely interleukin [IL]-1α, IL-1β, IL-6, IL-8 and tumor 
necrosis factor [TNF]-α). THCV was capable of suppressing the increase of these 
cytokines upon LPS treatment on the mRNA (Q-PCR; IL-1α, IL-1β, IL-6, IL-8, 
TNF-α) and for some the protein (ELISA; IL-6, IL-8) level. Therefore, THCV (at 
least in vitro) positively influences all sebocyte-specific aspects of acne 
pathogenesis. 
Based on our preliminary results, all pCBs tested have anti-inflammatory 
activity on human sebocytes 
In conclusion of our experiments exploring the effects of pCBs, we investigated 
the effects of CBC, CBDV, CBG, and CBGV on the immunological behavior of 
sebocytes. Using the inflammation model already presented for THCV, it was found 
that all pCBs significantly reduced the effect of LPS on mRNA expression of the 
above “acne-relevant” cytokines. 
NA does not reduce viability up to 100 µM 
In the second half of our experiments, we investigated the biological effects of 
NA, which has been used in clinical practice for decades as a lipid-lowering agent 
on human sebocytes. Using the MTT assay, we found that NA did not decrease the 
viability of sebocytes when used in concentrations up to 100 μM even after 24, 48 
and 72 hours of treatment. 
In order to exclude the possibility of early cell death processes, the effects of 
NA were further investigated with combined fluorescent DilC1(5)-SYTOX Green. 
We found that, in accordance with our data obtained with the MTT assay, NA did 
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not increase the proportion of apoptotic or necrotic cells, confirming that in this time 
(24-48 h) and concentration (1-100 μM) range it can be used without risk of 
cytotoxicity. 
NA does not affect homeostatic sebaceous lipid production, but normalizes 
acne-mimicking lipogenesis induced by various lipogenic agents 
Subsequently, we examined the effects of NA on the most characteristic 
biological function of sebocytes, i.e., basal, homeostatic sebaceous lipid production, 
using fluorescent Nile Red labeling. We found that the use of NA at the above non-
cytotoxic concentration does not affect the production of sebum lipids even after 48 
hours of treatment. 
Given that, as discussed above, one of the key steps in the pathogenesis of acne 
is abnormally increased sebum production, we next examined whether NA was able 
to suppress AA-induced acne-mimicking lipid synthesis. We found that the 
previously identified non-cytotoxic concentrations of NA significantly reduced AA-
induced, “acne-like”, pathologically increased lipid synthesis. 
NA has a universal lipostatic effect 
As in the previous series of experiments with pCBs, we were curious to note 
whether this remarkable lipostatic effect of NA is limited to the normalization of AA-
induced, predominantly PKCδ-mediated lipogenesis, or through activation of a 
universal lipostatic pathway. To address this issue, lipogenic agents (a combination 
of AEA already mentioned and linoleic acid [LA] and testosterone [T]) were used 
which, according to literature, enhance other signaling pathways (AEA: CB2; LA+T: 
PPARs). We found that both AEA and LA+T significantly increased sebaceous lipid 
production, whereas NA was able to counteract this effect in both cases. Based on 
these results NA is likely to have a universal lipostatic action. 
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NA reduces the proliferation of human sebocytes 
Based on the effects described above, it can be concluded that NA may be 
effective in the treatment of disorders associated with sebaceous gland hyperactivity 
(such as seborrhea or acne). Because sebum is produced via holocrine secretion, the 
actual amount of sebum depends not only on the lipid production, but also on the 
number of individual cells, the efficacy of an anti-seborrheic drug is greatly 
increased, if not only has lipostatic, but also anti-proliferative properties. Following 
this logic, the effects of NA on cell numbers were examined using the CyQUANT 
proliferation assay, and showed a small but significant reduction in sebocyte 
proliferation over the concentration range of 10-100 μM. It is also noteworthy that, 
in accordance with the viability data, the cell number did not fall below the 24-hour 
control level, confirming that NA was indeed not cytotoxic, but “purely” anti-
proliferative. 
NA does not protect the LPS-induced inflammatory response of sebocytes 
As discussed earlier, inflammation is another important factor in the 
development of acne besides pathologically increased sebaceous lipid production. 
With this in mind, we investigated how NA influences the immune profile of 
sebocytes as a conclusion of our phenomenological experiments. 
An immunogenic response was induced as above, with 5 μg/ml LPS, followed 
by cytokine expression and release experiments (IL-1α, IL-1β, IL-6, IL-8 and TNF-
α; Q-PCR; and IL-6 and IL-8; ELISA; 3- and 24-hour treatments). 
We found that NA at 100 μM did not reduce the LPS-induced increased 
production of these cytokines, nor did it have a significant effect on gene expression 
when used alone. We also examined how NA influences the release of two key 
cytokines, IL-6 and IL-8, through which recent data suggest that sebocytes are 
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involved in the regulation of Th17 cell activity. Consistent with mRNA data, we did 
not show any NA-dependent effect on cytokine release in either short- (3-hr) or long-
term (24-hr) treatments, suggesting that NA does not directly influence the 
inflammatory and immunological processes of human sebocytes. 
The lipostatic effect of NA occurs in a Ca2+-dependent manner 
We next decided to investigate the possible mechanisms underlying the above 
observed effects. Since elevation of [Ca2+]IC often leads to universal lipostatic effects 
very similar to those described above, and that NA has been shown to increase 
intracellular calcium in certain cell types, the question arose whether increase in 
[Ca2+]IC plays a role in mediating the lipostatic effects of NA. To answer this 
question, we first repeated the lipid synthesis assay in the presence of BAPTA AM 
a Ca2+ chelator. We found that the lipostatic effect of NA was not evident in the 
presence of 10 μM BAPTA AM, suggesting that Ca2+-linked signaling pathways may 
play a role in this effect. 
NA produces Ca2+ signal in human sebocytes, which is predominantly from the 
extracellular space, but is not TRP channel-mediated 
Since, based on the results described above, it seemed likely that NA could 
induce Ca2+ signaling in sebocytes, the next step was Fluo-4 AM labeling. Effective 
lipostatic concentrations of NA were found to increase [Ca2+]IC in a concentration-
dependent manner. 
Our next question was to identify the origin of the Ca2+ signal observed in the 
previous experiment. Performing the experiment in a nominally Ca2+-free medium, 
we found that the reduction of [Ca2+]EC almost completely prevented the Ca
2+ signal, 
suggesting that NA activates cell surface Ca2+ channels directly or indirectly on 
human sebocytes. NA is known to activate certain transient receptor potential (TRP) 
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channels of the vanilloid subfamily, which are mainly Ca2+-permeable, and that 
several of these channels (TRPV1, TRPV3, and TRPV4) are effective in reducing 
sebaceous lipid production. 
In order to investigate the possible involvement of these channels in the process, 
our experiments were also performed in the presence of the general TRP channel 
antagonist ruthenium red (RR). We found that RR did not influence NA-induced 
calcium signaling, suggesting that unidentified non-TRPV cell surface Ca2+ channels 
may be responsible. 
Sebocytes express the primary receptor of NA, HCA2 
In the light of the data presented above, the involvement of TRPV channels in 
mediating the lipostatic effects of NA seemed unlikely, so we next investigated the 
possible role of HCA2, considered as the primary receptor of NA. Q-PCR and 
immunofluorescent labeling revealed that HCA2 is present at both mRNA and 
protein levels in human sebocytes. 
Selective gene silencing of HCA2 prevents NA’s lipostatic and [Ca2+]IC 
increasing effects 
Given that no effective and selective antagonists are available against the HCA2 
receptor, siRNA transfection-mediated selective silencing was used, resulting in a 
significant decrease in HCA2 expression at both mRNA and protein levels. After 
verification of the success of gene silencing in SCR-transfected and HCA2 gene-
silenced sebocytes, we found that the cellular effects of NA were indeed HCA2-
mediated, as the lipostatic effect of NA and the Ca2+ signal it induced were also 
reduced. 
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Neither NA nor AA affect HCA2 receptor expression 
Based on these results, HCA2 is a novel, previously unknown regulator of 
human sebaceous lipid production, suggesting that changes in its expression and 
activity may play a role in mediating the effects of lipogenic agents such as AA. To 
conclude, we investigated how AA and NA treatments affect HCA2 expression in 
human sebocytes. We found that none of the treatments had a significant effect on 
protein expression of the receptor. 
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Discussion 
Acne is one of the most common human skin diseases, which, although not a 
life-threatening condition, can significantly impair patients’ quality of life. Given 
that the use of the most effective treatments currently available (such as oral 
isotretinoin) may lead to the development of serious adverse reactions, it is 
understandable that significant worldwide efforts are being made to develop new 
anti-acne drugs that are both safe and effective. 
An overview of the effects of selected non-psychotropic pCBs 
The ECS has a complex effect on the biological processes of human sebocytes: 
treatment with eCBs and enhancement of the eCB tone both increase sebaceous lipid 
production, whereas activation of the ionotropic cannabinoid receptors TRPV1, 
TRPV3, and TRPV4 reduces it. We have also shown that the use of CBD, the most 
studied and prescribed pCB, leads to the development of complex cellular anti-acne 
effects which, in the light of the available clinical trial data, are highly likely to occur 
in vivo as well. In light of these facts, we investigated in the first half of the present 
study whether non-psychotropic pCBs may have anti-acne effects similar to that of 
CBD. First, we determined that all five pCBs tested showed apoptosis-dominated 
cell death at 50-100 μM, but at ≤10 µM, they could be used without the risk of 
cytotoxicity. It was also shown that pCBs at these non-cytotoxic concentrations 
differentially influenced lipid synthesis. CBG and CBGV exhibited a small, but 
significant increase in lipogenesis in an “eCB-like” manner; “CBD-like” CBDV had 
no significant effect, whereas lipostatic CBC and THCV reduced basal sebaceous 
lipid synthesis. These results suggest that CBG and CBGV may have a beneficial 
effect on dry skin disorders, whereas CBC and especially THCV may have anti-acne 
effects. We found that CBC, CBDV and THCV, both at non-cytotoxic 
concentrations, significantly reduced the lipogenic effect of AA. Further examination 
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of the effects of THCV, which is the most efficient of the three pCBs, showed that it 
is likely that it activates a universal lipostatic signal pathway similarly to CBD, since 
it normalized not only AA-induced, but also eCB-dependent lipid production. Given 
that non-cytotoxic, effective lipostatic concentrations of THCV produced a dose-
dependent anti-proliferative effect, our data suggested that THCV could effectively 
reduce sebum production, even in vivo. In the next phase of our experiments, we 
demonstrated that THCV is highly effective in reducing the LPS-induced 
inflammatory response of sebocytes not only at mRNA, but also at protein level. 
Overall, therefore, our results showed that THCV positively influenced all sebocyte-
specific aspects of acne with comparable efficacy to CBD. 
As discussed above, our research has revealed interesting functional 
heterogeneity among pCBs. In contrast to the other three substances, CBG and 
CBGV behaved in an “eCB-like” manner, and slightly, but significantly increased 
sebaceous lipid synthesis in sebocytes. Given that our data obtained at mRNA level 
indicate that CBG and CBGV (as well as CBC and CBDV) are effective in reducing 
the LPS-induced inflammatory response of sebocytes, our results suggest that these 
compounds may be useful in the treatment of certain dermatites and inflammatory 
conditions. 
In terms of clinical translability of our results, it is worth noting that pCBs are 
well-tolerated even when administered orally, and topical CBD has been shown to 
be extremely safe in human studies. Given that all pCBs are highly lipophilic 
compounds, they are likely to enter the skin via the transfollicular route following 
topical application, and are likely to accumulate in lipid-rich SGs. These 
physicochemical properties make pCBs ideal candidate drugs for selectively 
targeting SGs, which can minimize the risk of systemic side effects. 
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Overview of the effects of NA on human sebocytes 
In the second half of our experiments, we focused on the biological effects of 
NA. We showed that NA at concentrations up to 100 µM did not affect the viability 
of sebocytes. NA did not induce early cell death processes, and did not affect basal, 
homeostatic sebaceous lipid production. At the same time, it normalized AA-induced 
enhanced lipid synthesis. In addition, the lipostatic effect of non-cytotoxic 
concentrations of NA was universal, as it prevented the action of not only AA, but 
also AEA (CB2) and LA+T combinations (PPARs) that activate partially independent 
signaling pathways. Finally, it has also been shown that the above non-cytotoxic 
concentrations of NA reduced the proliferation of sebocytes in a concentration-
dependent manner, suggesting that it may be effective in the normalization of 
pathologically increased sebum production in vivo. 
To investigate the mechanism of the observed beneficial effects, we first 
investigated the effects of NA on Ca2+ homeostasis since, according to our work and 
others, elevated [Ca2+]IC may lead to lipostatic effects similar to those seen now. We 
found that the effect of NA on lipid synthesis was indeed Ca2+-dependent, since the 
effects described above were abrogated in the presence of BAPTA-AM, a Ca2+-
chelator. We also demonstrated that lipostatic concentrations of NA increase the 
[Ca2+]IC of human sebocytes in a concentration-dependent manner, whereas the 
source of the Ca2+ signal is the extracellular space, since the Ca2+ signal was almost 
completely eliminated when nominally Ca2+-free solution was used. It is known that 
NA is capable of directly activating a number of predominantly Ca2+-permeable 
TRPV channels, which may exert a lipostatic effect similar to that seen in case of 
NA administration, therefore, we investigated whether these channels may contribute 
to the effects of NA. Given that NA-induced Ca2+ signal was not reduced by RR, a 
22 
general antagonist of TRPV channels, our results suggested that this effect may be 
due to a previously unknown, TRPV channel-independent mechanism. 
Further investigation of the possible mechanism has established the primary 
receptor of NA, HCA2, which we showed to be expressed at both mRNA (Q-PCR) 
and protein (IF) levels in sebocytes. In addition, selective “gene silencing” of the 
receptor by siRNA transfection prevented both lipostatic effects and Ca2+ signaling. 
Thus, our present data not only raise the potential for topical application of NA, 
which has been safely used in the clinic for decades, in acne and seborrhea, but also 
highlight the role of a previously unknown regulator, the HCA2 receptor, which may 
be an entirely new therapeutic target for these diseases. 
Of course, the therapeutic potential of our results should be explored in well-
designed, placebo-controlled, double-blind clinical trials. Although our team is not 
aware of such studies, in addition to the data presented above, there is ample evidence 
to support the notion that NA may be beneficial in acne and seborrhea. This evidence 
includes, firstly, the fact that pellagra (i.e., NA deficiency disease) is frequently 
characterized by “dyssebacia”, i.e., hyperplasia of sebocytes, altered sebum 
production, and consequent increase in SGs. Secondly, side effects of NA treatment 
at the pharmacological dose include dry skin. Third, the results of some (non-placebo 
controlled) pilot clinical trials suggest that oral NA can effectively reduce acne. 
It is also worth noting that another member of the vitamin B3 complex, 
nicotinamide, has been shown to effectively reduce sebum production in a double-
blind, placebo-controlled clinical trial, and overall there is growing evidence that it 
may be effective in treating acne and other skin conditions. Although the mechanism 
of action of nicotinamide against acne is only partially understood, it is known that 
it does not activate the HCA2 receptor, and thus does not activate the lipostatic 
signaling pathway described above in connection with NA. However, given that NA 
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can be converted to nicotinamide in vivo, the clinical efficacy of topical NA may 
even exceed that of nicotinamide, since it can theoretically produce both HCA2-
dependent direct and HCA2-independent, indirect anti-acne effects. 
Interestingly, despite its lipostatic and anti-proliferative efficacy, NA was 
unable to prevent the LPS-induced inflammatory response of sebocytes. It is worth 
noting, however, that based on our previous data obtained with CBD testing, the lack 
of anti-inflammatory effect of NA is not completely unexpected. According to our 
previous results, an independent anti-inflammatory pathway (adenosine A2A receptor 
 cAMP↑  TRIB3↑  inhibition of p65 NF-κB) is responsible for the relevant 
effects of CBD, while the lipostatic and anti-proliferative effects depend on the 
activation of TRPV4 ion channels and consequent Ca2+ signaling. In addition, it has 
recently been shown that activation of another Ca2+-permeable ion channel, namely 
TRPV3 (besides, just like TRPV1 and TRPV4, decreasing acne-mimicking 
excessive sebaceous lipid production) increased expression and release of several 
pro-inflammatory cytokines both in human sebocytes and keratinocytes. With these 
in mind, it is not surprising that NA, through activation of HCA2 and subsequent 
elevation of [Ca2+]IC, effectively normalized sebaceous lipid synthesis, but was 
unable to counteract the inflammatory response to LPS. 
Although our results suggest that HCA2 is a novel regulator of SG biology, an 
important question remains at the end of our experiments, namely how HCA2 
receptor activation can lead to [Ca2+]IC increase in human sebocytes. Although HCA2 
is a Gi-coupled receptor, it is not unprecedented in the literature for its activation to 
be followed by Ca2+ influx. Identification of the currently unknown Ca2+-permeable 
pore would be important because its direct pharmacological activation would add a 
new therapeutic target to treat acne and seborrhea. It should also be noted that, in 
contrast to TRPV3, where activation of the ion channel leads to the formation of an 
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inflammatory response in addition to the lipostatic effect, this unknown Ca2+ channel 
has been shown to influence the Ca2+ homeostasis of sebocytes in a manner that does 
not elicit an inflammatory response. 
Concluding thoughts - Limitations of this study 
Although promising experimental data has been presented above, the 
translational value of our study is limited by the fact that our findings are based on a 
single cell line due to the unfortunate lack of appropriate animal models and the 
objective difficulty of maintaining primary sebocyte cultures. However, since the 
cell model we have used to date has reliably predicted clinical efficacy in CBD, 
further studies of both pCB and NA in well-designed, randomized, double-blind, 
placebo-controlled clinical trials are warranted. These compounds hold promise to 
develop new drugs with a fundamentally novel mechanisms of action. 
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Summary 
In the first half of our experiments, we aimed to investigate the biological effects 
of certain non-psychotropic pCBs on human SZ95 sebocytes. We have shown that 
pCBs up to 10 μM have different effects on the most typical biological function of 
sebocytes, i.e. basal sebaceous lipid synthesis, without reducing cell viability. CBG 
and CBGV increased lipogenesis similarly to eCBs, CBDV had no significant effect, 
whereas CBC and THCV decreased basal sebaceous lipid synthesis. Because all 
pCBs were effective in reducing the LPS-induced inflammatory response of 
sebocytes, these results suggest that CBG and CBGV may have a beneficial effect 
on dermatitis-associated inflammatory disease. 
Continuing our experiments, we found that CBC, CBDV and THCV were able 
to significantly reduce AA-induced lipogenesis. Further examination of THCV, 
which was found to be the most effective of the above, found that it behaves as a 
“universal” lipostatic agent (i.e., it is also capable of blocking the action of lipogens 
acting on signaling pathways other than AA), is anti-proliferative, and almost 
completely normalizes LPS-induced expression of inflammatory cytokines. 
In the second half of our experiments, NA was found to effectively reduce 
sebocyte proliferation without affecting viability and homeostatic sebaceous lipid 
production, as well as pathologically enhanced sebaceous lipid synthesis induced by 
various lipogenic agents. It has also been shown that the effects of NA are mediated 
by HCA2 receptor activation and consequent Ca
2+ influx. 
Taken together, our results suggest that both NA and pCB have complex effects 
on the biological processes of human sebocytes, and may be promising new tools for 
treating various FM dysfunctions (dry skin, acne, seborrhea, etc.) 
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